Health
Beckman Coulter Launches Semi-Quantitative Access SARS-CoV-2 IgG II Antibody Test – HospiMedica
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patient’s relative level of antibodies in response to…
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patients relative level of antibodies in response to a previous SARS-CoV-2 infection. The assays new capabilities enable clinicians to establish a baseline to evaluate an individuals immune response to the SARS-CoV-2 virus based on a numerical value and assess relative changes of an individuals immune response to the virus over time. The assay may also help researchers as they begin to understand…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
General17 hours agoUK’s AUKUS inquiry is unlikely to suggest the government pull out, expert says
-
General24 hours agoFederal Labor candidate for Bass Jess Teesdale walks back support of end to native forestry
-
Noosa News22 hours agoDevastating update in search for missing Queensland mother Tayla Spies as police find human remains near her ute